4.1 Review

Mechanoregulation of Myofibroblast Fate and Cardiac Fibrosis

期刊

ADVANCED BIOSYSTEMS
卷 2, 期 1, 页码 -

出版社

WILEY-V C H VERLAG GMBH
DOI: 10.1002/adbi.201700172

关键词

biomechanics; cardiac engineering; fibrosis; mechanoregulation; myofibroblasts

资金

  1. National Institutes of Health [R21 EB020132, R01 HL135143]
  2. National Institute of Health [R00 HL119353]
  3. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL135143, R00HL119353] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB020132] Funding Source: NIH RePORTER

向作者/读者索取更多资源

During myocardial infarction, myocytes die and are replaced by a specialized fibrotic extracellular matrix, otherwise known as scarring. Fibrotic scarring presents a tremendous hemodynamic burden on the heart, as it creates a stiff substrate, which resists diastolic filling. Fibrotic mechanisms result in permanent scarring which often leads to hypertrophy, arrhythmias, and a rapid progression to failure. Despite the deep understanding of fibrosis in other tissues, acquired through previous investigations, the mechanisms of cardiac fibrosis remain unclear. Recent studies suggest that biochemical cues as well as mechanical cues regulate cells in myocardium. However, the steps in myofibroblast transdifferentiation, as well as the molecular mechanisms of such transdifferentiation in vivo, are poorly understood. This review is focused on defining myofibroblast physiology, scar mechanics, and examining current findings of myofibroblast regulation by mechanical stress, stiffness, and topography for understanding fibrotic disease dynamics.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据